Author

Matthew G. Fair

The Wistar Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

Emmanouil PapasavvasiD· 2 shared Karam MounzeriD· 2 shared Luis J. MontaneriD· 2 shared Pablo TebasiD· 2 shared Amit Bar‐OriD· 1 shared Andrea Preising· 1 shared Armando RodrígueziD· 1 shared Chiara PastorioiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Emmanouil PapasavvasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Retinol Binding Protein 4 reactivates latent HIV-1 via the JAK/STAT5 and JNK pathways

Chiara Pastorio, Khumoekae Richard, Manuel Hayn, Lennart Koepke, Andrea Preising, Nico Preising, Ludger Ständker, Matthew G. Fair, Jessicamarie Morris, Emmanouil Papasavvas, Honghong Sun, Armando Rodríguez, Karam Mounzer, Sebastian Wiese, Pablo Tebas, , Frank Kirchhoff

This study identifies Retinol Binding Protein 4 (RBP4) as a natural activator of latent HIV-1 through JAK/STAT5 and JNK pathways, offering a new strategy for reactivating viral reservoirs.

bioRxiv · Feb 26, 2025 · PreprintImmunology

Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies

Emmanouil Papasavvas, Lily D. Lu, Matthew G. Fair, Isabela Batista Oliva, Joel A. Cassel, Sonali Majumdar, Karam Mounzer, Jay R. Kostman, Pablo Tebas, Amit Bar‐Or, Kar Muthumani, Luis J. Montaner

The paper isolates and characterizes neutralizing anti-interferon-alpha and anti-interferon-beta antibodies from human patients, showing their specificity and potential therapeutic applications.

The Journal of Immunology · Aug 7, 2024Peer-reviewedImmunology